Global Hospital Infection Therapeutics Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023
Jan, 2019
|
Report ID: 31313
|
124
|
Pharmaceuticals and Healthcare
Hospital-acquired infections, also known as nosocomial infections, are acquired by patients in the hospitals or healthcare facilities. Urinary tract infections, bloodstream infections, surgical-site infections, Clostridium difficile associated diarrhea, and pneumonia are examples of nosocomial infections.
Scope of the Report:
This report studies the Hospital Infection Therapeutics market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Hospital Infection Therapeutics market by product type and applications/end industries.
The hospital infection therapeutics market is increasing at a significant rate, due to high susceptibility of neonatal population in healthcare setting and high occurrence of numerous hospital infections. Increasing incidences of hospital infections, high number of pipeline drug molecules for specific treatment of healthcare associated infections and high unaddressed needs in most of the countries are some of the factors providing ample opportunities for the hospital infection therapeutics market to grow in the coming years.
North America led the demand for hospital infection therapeutics market in 2017. The high prevalence of nosocomial infections has been identified as the key factor that has been driving the demand for infection therapeutics in North America and is projected to continue to do so throughout the forecast period. Although North America will remain the leading regional market for hospital infection therapeutics, it is Asia Pacific, which will present the most promising growth opportunities to this market in the near future.
The global Hospital Infection Therapeutics market is valued at 2700 million USD in 2017 and is expected to reach 3490 million USD by the end of 2023, growing at a CAGR of 4.4% between 2017 and 2023.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Hospital Infection Therapeutics.
Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.
Market Segment by Companies, this report covers
Bayer
Johnson & Johnson Services
Actavis
Sanofi
Bristol Myers Squibb Company
AstraZeneca
Pfizer
Merck
GlaxoSmithkline
Cubist Pharmaceuticals
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Antibacterial Drugs
Antiviral Drugs
Antifungal Drugs
Market Segment by Applications, can be divided into
Hospital Acquired Pneumonia
Surgical Site Infections
Urinary Tract Infection
Gastrointestinal Disorders
Bloodstream Infections
Others
Scope of the Report:
This report studies the Hospital Infection Therapeutics market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Hospital Infection Therapeutics market by product type and applications/end industries.
The hospital infection therapeutics market is increasing at a significant rate, due to high susceptibility of neonatal population in healthcare setting and high occurrence of numerous hospital infections. Increasing incidences of hospital infections, high number of pipeline drug molecules for specific treatment of healthcare associated infections and high unaddressed needs in most of the countries are some of the factors providing ample opportunities for the hospital infection therapeutics market to grow in the coming years.
North America led the demand for hospital infection therapeutics market in 2017. The high prevalence of nosocomial infections has been identified as the key factor that has been driving the demand for infection therapeutics in North America and is projected to continue to do so throughout the forecast period. Although North America will remain the leading regional market for hospital infection therapeutics, it is Asia Pacific, which will present the most promising growth opportunities to this market in the near future.
The global Hospital Infection Therapeutics market is valued at 2700 million USD in 2017 and is expected to reach 3490 million USD by the end of 2023, growing at a CAGR of 4.4% between 2017 and 2023.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Hospital Infection Therapeutics.
Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.
Market Segment by Companies, this report covers
Bayer
Johnson & Johnson Services
Actavis
Sanofi
Bristol Myers Squibb Company
AstraZeneca
Pfizer
Merck
GlaxoSmithkline
Cubist Pharmaceuticals
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Antibacterial Drugs
Antiviral Drugs
Antifungal Drugs
Market Segment by Applications, can be divided into
Hospital Acquired Pneumonia
Surgical Site Infections
Urinary Tract Infection
Gastrointestinal Disorders
Bloodstream Infections
Others
Frequently Asked Questions
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
- By Type
- By Application
- By Region
- By Country
- By Manufacturer
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Hospital Infection Therapeutics Market Overview
1.1 Product Overview and Scope of Hospital Infection Therapeutics
1.2 Classification of Hospital Infection Therapeutics by Types
1.2.1 Global Hospital Infection Therapeutics Revenue Comparison by Types (2017-2023)
1.2.2 Global Hospital Infection Therapeutics Revenue Market Share by Types in 2017
1.2.3 Antibacterial Drugs
1.2.4 Antiviral Drugs
1.2.5 Antifungal Drugs
1.3 Global Hospital Infection Therapeutics Market by Application
1.3.1 Global Hospital Infection Therapeutics Market Size and Market Share Comparison by Applications (2013-2023)
1.3.2 Hospital Acquired Pneumonia
1.3.3 Surgical Site Infections
1.3.4 Urinary Tract Infection
1.3.5 Gastrointestinal Disorders
1.3.6 Bloodstream Infections
1.3.7 Others
1.4 Global Hospital Infection Therapeutics Market by Regions
1.4.1 Global Hospital Infection Therapeutics Market Size (Million USD) Comparison by Regions (2013-2023)
1.4.1 North America (USA, Canada and Mexico) Hospital Infection Therapeutics Status and Prospect (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Hospital Infection Therapeutics Status and Prospect (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Hospital Infection Therapeutics Status and Prospect (2013-2023)
1.4.4 South America (Brazil, Argentina, Colombia) Hospital Infection Therapeutics Status and Prospect (2013-2023)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Hospital Infection Therapeutics Status and Prospect (2013-2023)
1.5 Global Market Size of Hospital Infection Therapeutics (2013-2023)
2 Manufacturers Profiles
2.1 Bayer
2.1.1 Business Overview
2.1.2 Hospital Infection Therapeutics Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Bayer Hospital Infection Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
2.2 Johnson & Johnson Services
2.2.1 Business Overview
2.2.2 Hospital Infection Therapeutics Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Johnson & Johnson Services Hospital Infection Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
2.3 Actavis
2.3.1 Business Overview
2.3.2 Hospital Infection Therapeutics Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Actavis Hospital Infection Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
2.4 Sanofi
2.4.1 Business Overview
2.4.2 Hospital Infection Therapeutics Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Sanofi Hospital Infection Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
2.5 Bristol Myers Squibb Company
2.5.1 Business Overview
2.5.2 Hospital Infection Therapeutics Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Bristol Myers Squibb Company Hospital Infection Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
2.6 AstraZeneca
2.6.1 Business Overview
2.6.2 Hospital Infection Therapeutics Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 AstraZeneca Hospital Infection Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
2.7 Pfizer
2.7.1 Business Overview
2.7.2 Hospital Infection Therapeutics Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Pfizer Hospital Infection Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
2.8 Merck
2.8.1 Business Overview
2.8.2 Hospital Infection Therapeutics Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Merck Hospital Infection Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
2.9 GlaxoSmithkline
2.9.1 Business Overview
2.9.2 Hospital Infection Therapeutics Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 GlaxoSmithkline Hospital Infection Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
2.10 Cubist Pharmaceuticals
2.10.1 Business Overview
2.10.2 Hospital Infection Therapeutics Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Cubist Pharmaceuticals Hospital Infection Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
3 Global Hospital Infection Therapeutics Market Competition, by Players
3.1 Global Hospital Infection Therapeutics Revenue and Share by Players (2013-2018)
3.2 Market Concentration Rate
3.2.1 Top 5 Hospital Infection Therapeutics Players Market Share
3.2.2 Top 10 Hospital Infection Therapeutics Players Market Share
3.3 Market Competition Trend
4 Global Hospital Infection Therapeutics Market Size by Regions
4.1 Global Hospital Infection Therapeutics Revenue and Market Share by Regions
4.2 North America Hospital Infection Therapeutics Revenue and Growth Rate (2013-2018)
4.3 Europe Hospital Infection Therapeutics Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Hospital Infection Therapeutics Revenue and Growth Rate (2013-2018)
4.5 South America Hospital Infection Therapeutics Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Hospital Infection Therapeutics Revenue and Growth Rate (2013-2018)
5 North America Hospital Infection Therapeutics Revenue by Countries
5.1 North America Hospital Infection Therapeutics Revenue by Countries (2013-2018)
5.2 USA Hospital Infection Therapeutics Revenue and Growth Rate (2013-2018)
5.3 Canada Hospital Infection Therapeutics Revenue and Growth Rate (2013-2018)
5.4 Mexico Hospital Infection Therapeutics Revenue and Growth Rate (2013-2018)
6 Europe Hospital Infection Therapeutics Revenue by Countries
6.1 Europe Hospital Infection Therapeutics Revenue by Countries (2013-2018)
6.2 Germany Hospital Infection Therapeutics Revenue and Growth Rate (2013-2018)
6.3 UK Hospital Infection Therapeutics Revenue and Growth Rate (2013-2018)
6.4 France Hospital Infection Therapeutics Revenue and Growth Rate (2013-2018)
6.5 Russia Hospital Infection Therapeutics Revenue and Growth Rate (2013-2018)
6.6 Italy Hospital Infection Therapeutics Revenue and Growth Rate (2013-2018)
7 Asia-Pacific Hospital Infection Therapeutics Revenue by Countries
7.1 Asia-Pacific Hospital Infection Therapeutics Revenue by Countries (2013-2018)
7.2 China Hospital Infection Therapeutics Revenue and Growth Rate (2013-2018)
7.3 Japan Hospital Infection Therapeutics Revenue and Growth Rate (2013-2018)
7.4 Korea Hospital Infection Therapeutics Revenue and Growth Rate (2013-2018)
7.5 India Hospital Infection Therapeutics Revenue and Growth Rate (2013-2018)
7.6 Southeast Asia Hospital Infection Therapeutics Revenue and Growth Rate (2013-2018)
8 South America Hospital Infection Therapeutics Revenue by Countries
8.1 South America Hospital Infection Therapeutics Revenue by Countries (2013-2018)
8.2 Brazil Hospital Infection Therapeutics Revenue and Growth Rate (2013-2018)
8.3 Argentina Hospital Infection Therapeutics Revenue and Growth Rate (2013-2018)
8.4 Colombia Hospital Infection Therapeutics Revenue and Growth Rate (2013-2018)
9 Middle East and Africa Revenue Hospital Infection Therapeutics by Countries
9.1 Middle East and Africa Hospital Infection Therapeutics Revenue by Countries (2013-2018)
9.2 Saudi Arabia Hospital Infection Therapeutics Revenue and Growth Rate (2013-2018)
9.3 UAE Hospital Infection Therapeutics Revenue and Growth Rate (2013-2018)
9.4 Egypt Hospital Infection Therapeutics Revenue and Growth Rate (2013-2018)
9.5 Nigeria Hospital Infection Therapeutics Revenue and Growth Rate (2013-2018)
9.6 South Africa Hospital Infection Therapeutics Revenue and Growth Rate (2013-2018)
10 Global Hospital Infection Therapeutics Market Segment by Type
10.1 Global Hospital Infection Therapeutics Revenue and Market Share by Type (2013-2018)
10.2 Global Hospital Infection Therapeutics Market Forecast by Type (2018-2023)
10.3 Antibacterial Drugs Revenue Growth Rate (2013-2023)
10.4 Antiviral Drugs Revenue Growth Rate (2013-2023)
10.5 Antifungal Drugs Revenue Growth Rate (2013-2023)
11 Global Hospital Infection Therapeutics Market Segment by Application
11.1 Global Hospital Infection Therapeutics Revenue Market Share by Application (2013-2018)
11.2 Hospital Infection Therapeutics Market Forecast by Application (2018-2023)
11.3 Hospital Acquired Pneumonia Revenue Growth (2013-2018)
11.4 Surgical Site Infections Revenue Growth (2013-2018)
11.5 Urinary Tract Infection Revenue Growth (2013-2018)
11.6 Gastrointestinal Disorders Revenue Growth (2013-2018)
11.7 Bloodstream Infections Revenue Growth (2013-2018)
11.8 Others Revenue Growth (2013-2018)
12 Global Hospital Infection Therapeutics Market Size Forecast (2018-2023)
12.1 Global Hospital Infection Therapeutics Market Size Forecast (2018-2023)
12.2 Global Hospital Infection Therapeutics Market Forecast by Regions (2018-2023)
12.3 North America Hospital Infection Therapeutics Revenue Market Forecast (2018-2023)
12.4 Europe Hospital Infection Therapeutics Revenue Market Forecast (2018-2023)
12.5 Asia-Pacific Hospital Infection Therapeutics Revenue Market Forecast (2018-2023)
12.6 South America Hospital Infection Therapeutics Revenue Market Forecast (2018-2023)
12.7 Middle East and Africa Hospital Infection Therapeutics Revenue Market Forecast (2018-2023)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
1 Hospital Infection Therapeutics Market Overview
1.1 Product Overview and Scope of Hospital Infection Therapeutics
1.2 Classification of Hospital Infection Therapeutics by Types
1.2.1 Global Hospital Infection Therapeutics Revenue Comparison by Types (2017-2023)
1.2.2 Global Hospital Infection Therapeutics Revenue Market Share by Types in 2017
1.2.3 Antibacterial Drugs
1.2.4 Antiviral Drugs
1.2.5 Antifungal Drugs
1.3 Global Hospital Infection Therapeutics Market by Application
1.3.1 Global Hospital Infection Therapeutics Market Size and Market Share Comparison by Applications (2013-2023)
1.3.2 Hospital Acquired Pneumonia
1.3.3 Surgical Site Infections
1.3.4 Urinary Tract Infection
1.3.5 Gastrointestinal Disorders
1.3.6 Bloodstream Infections
1.3.7 Others
1.4 Global Hospital Infection Therapeutics Market by Regions
1.4.1 Global Hospital Infection Therapeutics Market Size (Million USD) Comparison by Regions (2013-2023)
1.4.1 North America (USA, Canada and Mexico) Hospital Infection Therapeutics Status and Prospect (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Hospital Infection Therapeutics Status and Prospect (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Hospital Infection Therapeutics Status and Prospect (2013-2023)
1.4.4 South America (Brazil, Argentina, Colombia) Hospital Infection Therapeutics Status and Prospect (2013-2023)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Hospital Infection Therapeutics Status and Prospect (2013-2023)
1.5 Global Market Size of Hospital Infection Therapeutics (2013-2023)
2 Manufacturers Profiles
2.1 Bayer
2.1.1 Business Overview
2.1.2 Hospital Infection Therapeutics Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Bayer Hospital Infection Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
2.2 Johnson & Johnson Services
2.2.1 Business Overview
2.2.2 Hospital Infection Therapeutics Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Johnson & Johnson Services Hospital Infection Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
2.3 Actavis
2.3.1 Business Overview
2.3.2 Hospital Infection Therapeutics Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Actavis Hospital Infection Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
2.4 Sanofi
2.4.1 Business Overview
2.4.2 Hospital Infection Therapeutics Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Sanofi Hospital Infection Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
2.5 Bristol Myers Squibb Company
2.5.1 Business Overview
2.5.2 Hospital Infection Therapeutics Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Bristol Myers Squibb Company Hospital Infection Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
2.6 AstraZeneca
2.6.1 Business Overview
2.6.2 Hospital Infection Therapeutics Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 AstraZeneca Hospital Infection Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
2.7 Pfizer
2.7.1 Business Overview
2.7.2 Hospital Infection Therapeutics Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Pfizer Hospital Infection Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
2.8 Merck
2.8.1 Business Overview
2.8.2 Hospital Infection Therapeutics Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Merck Hospital Infection Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
2.9 GlaxoSmithkline
2.9.1 Business Overview
2.9.2 Hospital Infection Therapeutics Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 GlaxoSmithkline Hospital Infection Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
2.10 Cubist Pharmaceuticals
2.10.1 Business Overview
2.10.2 Hospital Infection Therapeutics Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Cubist Pharmaceuticals Hospital Infection Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
3 Global Hospital Infection Therapeutics Market Competition, by Players
3.1 Global Hospital Infection Therapeutics Revenue and Share by Players (2013-2018)
3.2 Market Concentration Rate
3.2.1 Top 5 Hospital Infection Therapeutics Players Market Share
3.2.2 Top 10 Hospital Infection Therapeutics Players Market Share
3.3 Market Competition Trend
4 Global Hospital Infection Therapeutics Market Size by Regions
4.1 Global Hospital Infection Therapeutics Revenue and Market Share by Regions
4.2 North America Hospital Infection Therapeutics Revenue and Growth Rate (2013-2018)
4.3 Europe Hospital Infection Therapeutics Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Hospital Infection Therapeutics Revenue and Growth Rate (2013-2018)
4.5 South America Hospital Infection Therapeutics Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Hospital Infection Therapeutics Revenue and Growth Rate (2013-2018)
5 North America Hospital Infection Therapeutics Revenue by Countries
5.1 North America Hospital Infection Therapeutics Revenue by Countries (2013-2018)
5.2 USA Hospital Infection Therapeutics Revenue and Growth Rate (2013-2018)
5.3 Canada Hospital Infection Therapeutics Revenue and Growth Rate (2013-2018)
5.4 Mexico Hospital Infection Therapeutics Revenue and Growth Rate (2013-2018)
6 Europe Hospital Infection Therapeutics Revenue by Countries
6.1 Europe Hospital Infection Therapeutics Revenue by Countries (2013-2018)
6.2 Germany Hospital Infection Therapeutics Revenue and Growth Rate (2013-2018)
6.3 UK Hospital Infection Therapeutics Revenue and Growth Rate (2013-2018)
6.4 France Hospital Infection Therapeutics Revenue and Growth Rate (2013-2018)
6.5 Russia Hospital Infection Therapeutics Revenue and Growth Rate (2013-2018)
6.6 Italy Hospital Infection Therapeutics Revenue and Growth Rate (2013-2018)
7 Asia-Pacific Hospital Infection Therapeutics Revenue by Countries
7.1 Asia-Pacific Hospital Infection Therapeutics Revenue by Countries (2013-2018)
7.2 China Hospital Infection Therapeutics Revenue and Growth Rate (2013-2018)
7.3 Japan Hospital Infection Therapeutics Revenue and Growth Rate (2013-2018)
7.4 Korea Hospital Infection Therapeutics Revenue and Growth Rate (2013-2018)
7.5 India Hospital Infection Therapeutics Revenue and Growth Rate (2013-2018)
7.6 Southeast Asia Hospital Infection Therapeutics Revenue and Growth Rate (2013-2018)
8 South America Hospital Infection Therapeutics Revenue by Countries
8.1 South America Hospital Infection Therapeutics Revenue by Countries (2013-2018)
8.2 Brazil Hospital Infection Therapeutics Revenue and Growth Rate (2013-2018)
8.3 Argentina Hospital Infection Therapeutics Revenue and Growth Rate (2013-2018)
8.4 Colombia Hospital Infection Therapeutics Revenue and Growth Rate (2013-2018)
9 Middle East and Africa Revenue Hospital Infection Therapeutics by Countries
9.1 Middle East and Africa Hospital Infection Therapeutics Revenue by Countries (2013-2018)
9.2 Saudi Arabia Hospital Infection Therapeutics Revenue and Growth Rate (2013-2018)
9.3 UAE Hospital Infection Therapeutics Revenue and Growth Rate (2013-2018)
9.4 Egypt Hospital Infection Therapeutics Revenue and Growth Rate (2013-2018)
9.5 Nigeria Hospital Infection Therapeutics Revenue and Growth Rate (2013-2018)
9.6 South Africa Hospital Infection Therapeutics Revenue and Growth Rate (2013-2018)
10 Global Hospital Infection Therapeutics Market Segment by Type
10.1 Global Hospital Infection Therapeutics Revenue and Market Share by Type (2013-2018)
10.2 Global Hospital Infection Therapeutics Market Forecast by Type (2018-2023)
10.3 Antibacterial Drugs Revenue Growth Rate (2013-2023)
10.4 Antiviral Drugs Revenue Growth Rate (2013-2023)
10.5 Antifungal Drugs Revenue Growth Rate (2013-2023)
11 Global Hospital Infection Therapeutics Market Segment by Application
11.1 Global Hospital Infection Therapeutics Revenue Market Share by Application (2013-2018)
11.2 Hospital Infection Therapeutics Market Forecast by Application (2018-2023)
11.3 Hospital Acquired Pneumonia Revenue Growth (2013-2018)
11.4 Surgical Site Infections Revenue Growth (2013-2018)
11.5 Urinary Tract Infection Revenue Growth (2013-2018)
11.6 Gastrointestinal Disorders Revenue Growth (2013-2018)
11.7 Bloodstream Infections Revenue Growth (2013-2018)
11.8 Others Revenue Growth (2013-2018)
12 Global Hospital Infection Therapeutics Market Size Forecast (2018-2023)
12.1 Global Hospital Infection Therapeutics Market Size Forecast (2018-2023)
12.2 Global Hospital Infection Therapeutics Market Forecast by Regions (2018-2023)
12.3 North America Hospital Infection Therapeutics Revenue Market Forecast (2018-2023)
12.4 Europe Hospital Infection Therapeutics Revenue Market Forecast (2018-2023)
12.5 Asia-Pacific Hospital Infection Therapeutics Revenue Market Forecast (2018-2023)
12.6 South America Hospital Infection Therapeutics Revenue Market Forecast (2018-2023)
12.7 Middle East and Africa Hospital Infection Therapeutics Revenue Market Forecast (2018-2023)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
List of Tables and Figures
Figure Hospital Infection Therapeutics Picture
Table Product Specifications of Hospital Infection Therapeutics
Table Global Hospital Infection Therapeutics and Revenue (Million USD) Market Split by Product Type
Figure Global Hospital Infection Therapeutics Revenue Market Share by Types in 2017
Figure Antibacterial Drugs Picture
Figure Antiviral Drugs Picture
Figure Antifungal Drugs Picture
Table Global Hospital Infection Therapeutics Revenue (Million USD) by Application (2013-2023)
Figure Hospital Infection Therapeutics Revenue Market Share by Applications in 2017
Figure Hospital Acquired Pneumonia Picture
Figure Surgical Site Infections Picture
Figure Urinary Tract Infection Picture
Figure Gastrointestinal Disorders Picture
Figure Bloodstream Infections Picture
Figure Others Picture
Table Global Market Hospital Infection Therapeutics Revenue (Million USD) Comparison by Regions 2013-2023
Figure North America Hospital Infection Therapeutics Revenue (Million USD) and Growth Rate (2013-2023)
Figure Europe Hospital Infection Therapeutics Revenue (Million USD) and Growth Rate (2013-2023)
Figure Asia-Pacific Hospital Infection Therapeutics Revenue (Million USD) and Growth Rate (2013-2023)
Figure South America Hospital Infection Therapeutics Revenue (Million USD) and Growth Rate (2013-2023)
Figure Middle East and Africa Hospital Infection Therapeutics Revenue (Million USD) and Growth Rate (2013-2023)
Figure Global Hospital Infection Therapeutics Revenue (Million USD) and Growth Rate (2013-2023)
Table Bayer Basic Information, Manufacturing Base and Competitors
Table Bayer Hospital Infection Therapeutics Type and Applications
Table Bayer Hospital Infection Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
Table Johnson & Johnson Services Basic Information, Manufacturing Base and Competitors
Table Johnson & Johnson Services Hospital Infection Therapeutics Type and Applications
Table Johnson & Johnson Services Hospital Infection Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
Table Actavis Basic Information, Manufacturing Base and Competitors
Table Actavis Hospital Infection Therapeutics Type and Applications
Table Actavis Hospital Infection Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
Table Sanofi Basic Information, Manufacturing Base and Competitors
Table Sanofi Hospital Infection Therapeutics Type and Applications
Table Sanofi Hospital Infection Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
Table Bristol Myers Squibb Company Basic Information, Manufacturing Base and Competitors
Table Bristol Myers Squibb Company Hospital Infection Therapeutics Type and Applications
Table Bristol Myers Squibb Company Hospital Infection Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
Table AstraZeneca Basic Information, Manufacturing Base and Competitors
Table AstraZeneca Hospital Infection Therapeutics Type and Applications
Table AstraZeneca Hospital Infection Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
Table Pfizer Basic Information, Manufacturing Base and Competitors
Table Pfizer Hospital Infection Therapeutics Type and Applications
Table Pfizer Hospital Infection Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
Table Merck Basic Information, Manufacturing Base and Competitors
Table Merck Hospital Infection Therapeutics Type and Applications
Table Merck Hospital Infection Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
Table GlaxoSmithkline Basic Information, Manufacturing Base and Competitors
Table GlaxoSmithkline Hospital Infection Therapeutics Type and Applications
Table GlaxoSmithkline Hospital Infection Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
Table Cubist Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table Cubist Pharmaceuticals Hospital Infection Therapeutics Type and Applications
Table Cubist Pharmaceuticals Hospital Infection Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
Table Global Hospital Infection Therapeutics Revenue (Million USD) by Players (2013-2018)
Table Global Hospital Infection Therapeutics Revenue Share by Players (2013-2018)
Figure Global Hospital Infection Therapeutics Revenue Share by Players in 2016
Figure Global Hospital Infection Therapeutics Revenue Share by Players in 2017
Figure Global Top 5 Players Hospital Infection Therapeutics Revenue Market Share in 2017
Figure Global Top 10 Players Hospital Infection Therapeutics Revenue Market Share in 2017
Figure Global Hospital Infection Therapeutics Revenue (Million USD) and Growth Rate (%) (2013-2018)
Table Global Hospital Infection Therapeutics Revenue (Million USD) by Regions (2013-2018)
Table Global Hospital Infection Therapeutics Revenue Market Share by Regions (2013-2018)
Figure Global Hospital Infection Therapeutics Revenue Market Share by Regions (2013-2018)
Figure Global Hospital Infection Therapeutics Revenue Market Share by Regions in 2017
Figure North America Hospital Infection Therapeutics Revenue and Growth Rate (2013-2018)
Figure Europe Hospital Infection Therapeutics Revenue and Growth Rate (2013-2018)
Figure Asia-Pacific Hospital Infection Therapeutics Revenue and Growth Rate (2013-2018)
Figure South America Hospital Infection Therapeutics Revenue and Growth Rate (2013-2018)
Figure Middle East and Africa Hospital Infection Therapeutics Revenue and Growth Rate (2013-2018)
Table North America Hospital Infection Therapeutics Revenue by Countries (2013-2018)
Table North America Hospital Infection Therapeutics Revenue Market Share by Countries (2013-2018)
Figure North America Hospital Infection Therapeutics Revenue Market Share by Countries (2013-2018)
Figure North America Hospital Infection Therapeutics Revenue Market Share by Countries in 2017
Figure USA Hospital Infection Therapeutics Revenue and Growth Rate (2013-2018)
Figure Canada Hospital Infection Therapeutics Revenue and Growth Rate (2013-2018)
Figure Mexico Hospital Infection Therapeutics Revenue and Growth Rate (2013-2018)
Table Europe Hospital Infection Therapeutics Revenue (Million USD) by Countries (2013-2018)
Figure Europe Hospital Infection Therapeutics Revenue Market Share by Countries (2013-2018)
Figure Europe Hospital Infection Therapeutics Revenue Market Share by Countries in 2017
Figure Germany Hospital Infection Therapeutics Revenue and Growth Rate (2013-2018)
Figure UK Hospital Infection Therapeutics Revenue and Growth Rate (2013-2018)
Figure France Hospital Infection Therapeutics Revenue and Growth Rate (2013-2018)
Figure Russia Hospital Infection Therapeutics Revenue and Growth Rate (2013-2018)
Figure Italy Hospital Infection Therapeutics Revenue and Growth Rate (2013-2018)
Table Asia-Pacific Hospital Infection Therapeutics Revenue (Million USD) by Countries (2013-2018)
Figure Asia-Pacific Hospital Infection Therapeutics Revenue Market Share by Countries (2013-2018)
Figure Asia-Pacific Hospital Infection Therapeutics Revenue Market Share by Countries in 2017
Figure China Hospital Infection Therapeutics Revenue and Growth Rate (2013-2018)
Figure Japan Hospital Infection Therapeutics Revenue and Growth Rate (2013-2018)
Figure Korea Hospital Infection Therapeutics Revenue and Growth Rate (2013-2018)
Figure India Hospital Infection Therapeutics Revenue and Growth Rate (2013-2018)
Figure Southeast Asia Hospital Infection Therapeutics Revenue and Growth Rate (2013-2018)
Table South America Hospital Infection Therapeutics Revenue by Countries (2013-2018)
Table South America Hospital Infection Therapeutics Revenue Market Share by Countries (2013-2018)
Figure South America Hospital Infection Therapeutics Revenue Market Share by Countries (2013-2018)
Figure South America Hospital Infection Therapeutics Revenue Market Share by Countries in 2017
Figure Brazil Hospital Infection Therapeutics Revenue and Growth Rate (2013-2018)
Figure Argentina Hospital Infection Therapeutics Revenue and Growth Rate (2013-2018)
Figure Colombia Hospital Infection Therapeutics Revenue and Growth Rate (2013-2018)
Table Middle East and Africa Hospital Infection Therapeutics Revenue (Million USD) by Countries (2013-2018)
Table Middle East and Africa Hospital Infection Therapeutics Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Hospital Infection Therapeutics Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Hospital Infection Therapeutics Revenue Market Share by Countries in 2017
Figure Saudi Arabia Hospital Infection Therapeutics Revenue and Growth Rate (2013-2018)
Figure UAE Hospital Infection Therapeutics Revenue and Growth Rate (2013-2018)
Figure Egypt Hospital Infection Therapeutics Revenue and Growth Rate (2013-2018)
Figure Nigeria Hospital Infection Therapeutics Revenue and Growth Rate (2013-2018)
Figure South Africa Hospital Infection Therapeutics Revenue and Growth Rate (2013-2018)
Table Global Hospital Infection Therapeutics Revenue (Million USD) by Type (2013-2018)
Table Global Hospital Infection Therapeutics Revenue Share by Type (2013-2018)
Figure Global Hospital Infection Therapeutics Revenue Share by Type (2013-2018)
Figure Global Hospital Infection Therapeutics Revenue Share by Type in 2017
Table Global Hospital Infection Therapeutics Revenue Forecast by Type (2018-2023)
Figure Global Hospital Infection Therapeutics Market Share Forecast by Type (2018-2023)
Figure Global Antibacterial Drugs Revenue Growth Rate (2013-2018)
Figure Global Antiviral Drugs Revenue Growth Rate (2013-2018)
Figure Global Antifungal Drugs Revenue Growth Rate (2013-2018)
Table Global Hospital Infection Therapeutics Revenue by Application (2013-2018)
Table Global Hospital Infection Therapeutics Revenue Share by Application (2013-2018)
Figure Global Hospital Infection Therapeutics Revenue Share by Application (2013-2018)
Figure Global Hospital Infection Therapeutics Revenue Share by Application in 2017
Table Global Hospital Infection Therapeutics Revenue Forecast by Application (2018-2023)
Figure Global Hospital Infection Therapeutics Market Share Forecast by Application (2018-2023)
Figure Global Hospital Acquired Pneumonia Revenue Growth Rate (2013-2018)
Figure Global Surgical Site Infections Revenue Growth Rate (2013-2018)
Figure Global Urinary Tract Infection Revenue Growth Rate (2013-2018)
Figure Global Gastrointestinal Disorders Revenue Growth Rate (2013-2018)
Figure Global Bloodstream Infections Revenue Growth Rate (2013-2018)
Figure Global Others Revenue Growth Rate (2013-2018)
Figure Global Hospital Infection Therapeutics Revenue (Million USD) and Growth Rate Forecast (2018 -2023)
Table Global Hospital Infection Therapeutics Revenue (Million USD) Forecast by Regions (2018-2023)
Figure Global Hospital Infection Therapeutics Revenue Market Share Forecast by Regions (2018-2023)
Figure North America Hospital Infection Therapeutics Revenue Market Forecast (2018-2023)
Figure Europe Hospital Infection Therapeutics Revenue Market Forecast (2018-2023)
Figure Asia-Pacific Hospital Infection Therapeutics Revenue Market Forecast (2018-2023)
Figure South America Hospital Infection Therapeutics Revenue Market Forecast (2018-2023)
Figure Middle East and Africa Hospital Infection Therapeutics Revenue Market Forecast (2018-2023)
Figure Hospital Infection Therapeutics Picture
Table Product Specifications of Hospital Infection Therapeutics
Table Global Hospital Infection Therapeutics and Revenue (Million USD) Market Split by Product Type
Figure Global Hospital Infection Therapeutics Revenue Market Share by Types in 2017
Figure Antibacterial Drugs Picture
Figure Antiviral Drugs Picture
Figure Antifungal Drugs Picture
Table Global Hospital Infection Therapeutics Revenue (Million USD) by Application (2013-2023)
Figure Hospital Infection Therapeutics Revenue Market Share by Applications in 2017
Figure Hospital Acquired Pneumonia Picture
Figure Surgical Site Infections Picture
Figure Urinary Tract Infection Picture
Figure Gastrointestinal Disorders Picture
Figure Bloodstream Infections Picture
Figure Others Picture
Table Global Market Hospital Infection Therapeutics Revenue (Million USD) Comparison by Regions 2013-2023
Figure North America Hospital Infection Therapeutics Revenue (Million USD) and Growth Rate (2013-2023)
Figure Europe Hospital Infection Therapeutics Revenue (Million USD) and Growth Rate (2013-2023)
Figure Asia-Pacific Hospital Infection Therapeutics Revenue (Million USD) and Growth Rate (2013-2023)
Figure South America Hospital Infection Therapeutics Revenue (Million USD) and Growth Rate (2013-2023)
Figure Middle East and Africa Hospital Infection Therapeutics Revenue (Million USD) and Growth Rate (2013-2023)
Figure Global Hospital Infection Therapeutics Revenue (Million USD) and Growth Rate (2013-2023)
Table Bayer Basic Information, Manufacturing Base and Competitors
Table Bayer Hospital Infection Therapeutics Type and Applications
Table Bayer Hospital Infection Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
Table Johnson & Johnson Services Basic Information, Manufacturing Base and Competitors
Table Johnson & Johnson Services Hospital Infection Therapeutics Type and Applications
Table Johnson & Johnson Services Hospital Infection Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
Table Actavis Basic Information, Manufacturing Base and Competitors
Table Actavis Hospital Infection Therapeutics Type and Applications
Table Actavis Hospital Infection Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
Table Sanofi Basic Information, Manufacturing Base and Competitors
Table Sanofi Hospital Infection Therapeutics Type and Applications
Table Sanofi Hospital Infection Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
Table Bristol Myers Squibb Company Basic Information, Manufacturing Base and Competitors
Table Bristol Myers Squibb Company Hospital Infection Therapeutics Type and Applications
Table Bristol Myers Squibb Company Hospital Infection Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
Table AstraZeneca Basic Information, Manufacturing Base and Competitors
Table AstraZeneca Hospital Infection Therapeutics Type and Applications
Table AstraZeneca Hospital Infection Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
Table Pfizer Basic Information, Manufacturing Base and Competitors
Table Pfizer Hospital Infection Therapeutics Type and Applications
Table Pfizer Hospital Infection Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
Table Merck Basic Information, Manufacturing Base and Competitors
Table Merck Hospital Infection Therapeutics Type and Applications
Table Merck Hospital Infection Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
Table GlaxoSmithkline Basic Information, Manufacturing Base and Competitors
Table GlaxoSmithkline Hospital Infection Therapeutics Type and Applications
Table GlaxoSmithkline Hospital Infection Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
Table Cubist Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table Cubist Pharmaceuticals Hospital Infection Therapeutics Type and Applications
Table Cubist Pharmaceuticals Hospital Infection Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
Table Global Hospital Infection Therapeutics Revenue (Million USD) by Players (2013-2018)
Table Global Hospital Infection Therapeutics Revenue Share by Players (2013-2018)
Figure Global Hospital Infection Therapeutics Revenue Share by Players in 2016
Figure Global Hospital Infection Therapeutics Revenue Share by Players in 2017
Figure Global Top 5 Players Hospital Infection Therapeutics Revenue Market Share in 2017
Figure Global Top 10 Players Hospital Infection Therapeutics Revenue Market Share in 2017
Figure Global Hospital Infection Therapeutics Revenue (Million USD) and Growth Rate (%) (2013-2018)
Table Global Hospital Infection Therapeutics Revenue (Million USD) by Regions (2013-2018)
Table Global Hospital Infection Therapeutics Revenue Market Share by Regions (2013-2018)
Figure Global Hospital Infection Therapeutics Revenue Market Share by Regions (2013-2018)
Figure Global Hospital Infection Therapeutics Revenue Market Share by Regions in 2017
Figure North America Hospital Infection Therapeutics Revenue and Growth Rate (2013-2018)
Figure Europe Hospital Infection Therapeutics Revenue and Growth Rate (2013-2018)
Figure Asia-Pacific Hospital Infection Therapeutics Revenue and Growth Rate (2013-2018)
Figure South America Hospital Infection Therapeutics Revenue and Growth Rate (2013-2018)
Figure Middle East and Africa Hospital Infection Therapeutics Revenue and Growth Rate (2013-2018)
Table North America Hospital Infection Therapeutics Revenue by Countries (2013-2018)
Table North America Hospital Infection Therapeutics Revenue Market Share by Countries (2013-2018)
Figure North America Hospital Infection Therapeutics Revenue Market Share by Countries (2013-2018)
Figure North America Hospital Infection Therapeutics Revenue Market Share by Countries in 2017
Figure USA Hospital Infection Therapeutics Revenue and Growth Rate (2013-2018)
Figure Canada Hospital Infection Therapeutics Revenue and Growth Rate (2013-2018)
Figure Mexico Hospital Infection Therapeutics Revenue and Growth Rate (2013-2018)
Table Europe Hospital Infection Therapeutics Revenue (Million USD) by Countries (2013-2018)
Figure Europe Hospital Infection Therapeutics Revenue Market Share by Countries (2013-2018)
Figure Europe Hospital Infection Therapeutics Revenue Market Share by Countries in 2017
Figure Germany Hospital Infection Therapeutics Revenue and Growth Rate (2013-2018)
Figure UK Hospital Infection Therapeutics Revenue and Growth Rate (2013-2018)
Figure France Hospital Infection Therapeutics Revenue and Growth Rate (2013-2018)
Figure Russia Hospital Infection Therapeutics Revenue and Growth Rate (2013-2018)
Figure Italy Hospital Infection Therapeutics Revenue and Growth Rate (2013-2018)
Table Asia-Pacific Hospital Infection Therapeutics Revenue (Million USD) by Countries (2013-2018)
Figure Asia-Pacific Hospital Infection Therapeutics Revenue Market Share by Countries (2013-2018)
Figure Asia-Pacific Hospital Infection Therapeutics Revenue Market Share by Countries in 2017
Figure China Hospital Infection Therapeutics Revenue and Growth Rate (2013-2018)
Figure Japan Hospital Infection Therapeutics Revenue and Growth Rate (2013-2018)
Figure Korea Hospital Infection Therapeutics Revenue and Growth Rate (2013-2018)
Figure India Hospital Infection Therapeutics Revenue and Growth Rate (2013-2018)
Figure Southeast Asia Hospital Infection Therapeutics Revenue and Growth Rate (2013-2018)
Table South America Hospital Infection Therapeutics Revenue by Countries (2013-2018)
Table South America Hospital Infection Therapeutics Revenue Market Share by Countries (2013-2018)
Figure South America Hospital Infection Therapeutics Revenue Market Share by Countries (2013-2018)
Figure South America Hospital Infection Therapeutics Revenue Market Share by Countries in 2017
Figure Brazil Hospital Infection Therapeutics Revenue and Growth Rate (2013-2018)
Figure Argentina Hospital Infection Therapeutics Revenue and Growth Rate (2013-2018)
Figure Colombia Hospital Infection Therapeutics Revenue and Growth Rate (2013-2018)
Table Middle East and Africa Hospital Infection Therapeutics Revenue (Million USD) by Countries (2013-2018)
Table Middle East and Africa Hospital Infection Therapeutics Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Hospital Infection Therapeutics Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Hospital Infection Therapeutics Revenue Market Share by Countries in 2017
Figure Saudi Arabia Hospital Infection Therapeutics Revenue and Growth Rate (2013-2018)
Figure UAE Hospital Infection Therapeutics Revenue and Growth Rate (2013-2018)
Figure Egypt Hospital Infection Therapeutics Revenue and Growth Rate (2013-2018)
Figure Nigeria Hospital Infection Therapeutics Revenue and Growth Rate (2013-2018)
Figure South Africa Hospital Infection Therapeutics Revenue and Growth Rate (2013-2018)
Table Global Hospital Infection Therapeutics Revenue (Million USD) by Type (2013-2018)
Table Global Hospital Infection Therapeutics Revenue Share by Type (2013-2018)
Figure Global Hospital Infection Therapeutics Revenue Share by Type (2013-2018)
Figure Global Hospital Infection Therapeutics Revenue Share by Type in 2017
Table Global Hospital Infection Therapeutics Revenue Forecast by Type (2018-2023)
Figure Global Hospital Infection Therapeutics Market Share Forecast by Type (2018-2023)
Figure Global Antibacterial Drugs Revenue Growth Rate (2013-2018)
Figure Global Antiviral Drugs Revenue Growth Rate (2013-2018)
Figure Global Antifungal Drugs Revenue Growth Rate (2013-2018)
Table Global Hospital Infection Therapeutics Revenue by Application (2013-2018)
Table Global Hospital Infection Therapeutics Revenue Share by Application (2013-2018)
Figure Global Hospital Infection Therapeutics Revenue Share by Application (2013-2018)
Figure Global Hospital Infection Therapeutics Revenue Share by Application in 2017
Table Global Hospital Infection Therapeutics Revenue Forecast by Application (2018-2023)
Figure Global Hospital Infection Therapeutics Market Share Forecast by Application (2018-2023)
Figure Global Hospital Acquired Pneumonia Revenue Growth Rate (2013-2018)
Figure Global Surgical Site Infections Revenue Growth Rate (2013-2018)
Figure Global Urinary Tract Infection Revenue Growth Rate (2013-2018)
Figure Global Gastrointestinal Disorders Revenue Growth Rate (2013-2018)
Figure Global Bloodstream Infections Revenue Growth Rate (2013-2018)
Figure Global Others Revenue Growth Rate (2013-2018)
Figure Global Hospital Infection Therapeutics Revenue (Million USD) and Growth Rate Forecast (2018 -2023)
Table Global Hospital Infection Therapeutics Revenue (Million USD) Forecast by Regions (2018-2023)
Figure Global Hospital Infection Therapeutics Revenue Market Share Forecast by Regions (2018-2023)
Figure North America Hospital Infection Therapeutics Revenue Market Forecast (2018-2023)
Figure Europe Hospital Infection Therapeutics Revenue Market Forecast (2018-2023)
Figure Asia-Pacific Hospital Infection Therapeutics Revenue Market Forecast (2018-2023)
Figure South America Hospital Infection Therapeutics Revenue Market Forecast (2018-2023)
Figure Middle East and Africa Hospital Infection Therapeutics Revenue Market Forecast (2018-2023)
